<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Renal function following xenon anesthesia for partial nephrectomy-An explorative analysis of a randomized controlled study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-07-18">July 18, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Ana</forename><surname>Stevanovic</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology</orgName>
								<orgName type="institution">University Hospital RWTH Aachen</orgName>
								<address>
									<settlement>Aachen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patrick</forename><surname>Schaefer</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Medical Faculty</orgName>
								<orgName type="institution">University of RWTH Aachen</orgName>
								<address>
									<settlement>Aachen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mark</forename><surname>Coburn</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology</orgName>
								<orgName type="institution">University Hospital RWTH Aachen</orgName>
								<address>
									<settlement>Aachen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rolf</forename><surname>Rossaint</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology</orgName>
								<orgName type="institution">University Hospital RWTH Aachen</orgName>
								<address>
									<settlement>Aachen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Stoppe</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology</orgName>
								<orgName type="institution">University Hospital RWTH Aachen</orgName>
								<address>
									<settlement>Aachen, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Intensive Care Medicine</orgName>
								<orgName type="institution">University Hospital of RWTH Aachen</orgName>
								<address>
									<settlement>Aachen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Boor</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital of RWTH Aachen</orgName>
								<address>
									<settlement>Aachen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><surname>Pfister</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Axel</forename><surname>Heidenreich</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hildegard</forename><surname>Christ</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Institute of Medical Statistics</orgName>
								<orgName type="department" key="dep2">Informatics and Epidemiology (IMSIE)</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Hellmich</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Institute of Medical Statistics</orgName>
								<orgName type="department" key="dep2">Informatics and Epidemiology (IMSIE)</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Astrid</forename><forename type="middle">V</forename><surname>Fahlenkamp</surname></persName>
							<email>astrid.fahlenkamp@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology</orgName>
								<orgName type="institution">University Hospital RWTH Aachen</orgName>
								<address>
									<settlement>Aachen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="institution" key="instit1">Iratxe Puebla</orgName>
								<orgName type="institution" key="instit2">Public Library of Science</orgName>
								<address>
									<country key="FR">FRANCE</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Renal function following xenon anesthesia for partial nephrectomy-An explorative analysis of a randomized controlled study</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-07-18">July 18, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">AE70B858CD4060538DF2665CB6DBF285</idno>
					<idno type="DOI">10.1371/journal.pone.0181022</idno>
					<note type="submission">Received: November 11, 2016 Accepted: June 20, 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:39+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Perioperative preservation of renal function has a significant impact on morbidity and mortality in kidney surgery.</s><s>Nephroprotective effects of the anesthetic xenon on ischemia-reperfusion injury were found in several experimental studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Objective</head><p><s>We aimed to explore whether xenon anesthesia can reduce renal damage in humans undergoing partial nephrectomy and to gather pilot data of possible nephroprotection in these patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Design</head><p><s>A prospective randomized, single-blinded, controlled study.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>The worldwide ninth most common type of cancer in men is renal cell carcinoma (RCC), with an increasing incidence <ref type="bibr" target="#b0">[1]</ref>.</s><s>Due to the extended use of surgery, kidney cancer mortality shows a decline in high-resource countries <ref type="bibr" target="#b0">[1]</ref>.</s><s>A partial nephrectomy (PN) with preservation of nephrons is recommended in early-stage RCCs restricted to one kidney <ref type="bibr" target="#b1">[2]</ref>.</s><s>Notwithstanding the nephron-sparing effect of PN compared to radical nephrectomy, a postoperative impairment of renal function is common <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>.</s><s>Despite its often transient nature, a clinically significant GFR decrease of 16-30% is observed in the first days following surgery <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref>.</s><s>Early impaired renal function occurs regardless of renal hilar clamping, thus attracting interest to a mechanism of indirect ischemia and reperfusion injury (IRI) involving tumor manipulation and resection itself <ref type="bibr" target="#b2">[3]</ref>.</s><s>Despite protocols to shorten manipulation time, the use of cold ischemia, administration of mannitol, adequate hydration, avoidance of hypotension and blood loss, a postoperative GFR decline cannot fully be prevented <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s>After PN the GFR shows an initial nadir, followed by recovery to new reduced baseline levels <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s>In elderly patients with pre-existing latent GFR decrease these reduced baseline levels often result in a clinically relevant chronically reduced renal function <ref type="bibr" target="#b3">[4]</ref>.</s><s>Plus, a large body of evidence showed that acute kidney injury (AKI), as induced by IRI, predisposes to chronic kidney disease (CKD) <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>.</s><s>CKD is associated with a significant individual morbidity and mortality, and a high Competing interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: MC and RR have received lecture and consultant fees from Air Liquide Sante ´International, a company interested in developing clinical applications for medical gases, including xenon.</s><s>MC and RR have ongoing consultancy contracts with AirLiquide and Baxter.</s><s>MC has received a grant from Baxter Healthcare Corporation, USA for activities outside the submitted work.</s><s>RR has received funding from Air Liquide Sante ´International for past activities outside the submitted work.</s><s>AS has been compensated for travel expenses for an investigator meeting by Air Liquide Sante Ínternational.</s><s>For the remaining authors no conflicts of interest are declared.</s><s>This does not alter our adherence to PLOS ONE policies on sharing data and materials.</s><s>socioeconomic burden.</s><s>A therapeutic approach enhancing kidney-resilience to IRI would be of outstanding clinical relevance <ref type="bibr" target="#b5">[6]</ref>.</s></p><p><s>The noble gas xenon (Xe) is approved for clinical routine use as an inhalational anesthetic with favorable properties <ref type="bibr" target="#b6">[7]</ref>.</s><s>Different experimental in vitro and in vivo models were able to demonstrate the neuroprotective <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref> and cardioprotective <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref> effects induced by Xe treatment.</s><s>First approaches translating these results into clinical practice showed promising neuroprotective properties of Xe in newborn infants with perinatal asphyxia <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref> and in patients after out-of-hospital cardiac arrest <ref type="bibr" target="#b18">[19]</ref>.</s></p><p><s>Nephroprotection by Xe was recently revealed in both in vivo and in vitro IRI kidney models <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref>.</s><s>Xenon "preconditioning" was identified as one reason for nephroprotection.</s><s>The underlying mechanisms of Xe "preconditioning" include the activation of HIF-1α <ref type="bibr" target="#b20">[21]</ref> micro-RNA (miR-21) <ref type="bibr" target="#b22">[23]</ref> and other cell survival factors like phospho-Akt <ref type="bibr" target="#b21">[22]</ref>.</s><s>They all act via several interrelated pathways enhancing cellular ischemia-tolerance, attenuation of renal tubular damage and apoptosis.</s><s>Additionally, a nephroprotective effect of Xe by "pre-and postconditioning" was shown in rat models of renal transplantation <ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref>.</s><s>Xe exposure of donors or recipients induced tubular cell proliferation, reduced cell death and inflammation.</s><s>This was related to an increased expression of insulin growth factor-1 (IGF-1) and its receptor in human proximal tubular (HK-2) cells, in connection with downstream HIF-1α activation <ref type="bibr" target="#b25">[26]</ref>.</s><s>Clinically, the first hint to improved renal function following Xe anesthesia was found in patients undergoing cardiac surgery <ref type="bibr" target="#b26">[27]</ref>.</s><s>The effects of xenon anesthesia on renal function in patients with kidney surgery have not yet been investigated.</s></p><p><s>The aim of this explorative study was to explore whether xenon anesthesia can reduce renal damage in humans undergoing PN.</s><s>The primary outcome variable was chosen to be the maximum post-operative decrease of GFR within the first seven days following surgery.</s><s>Within this study, we intended to gather preliminary data of potential clinically relevant nephroprotection in the study subjects, comparing the early postoperative reduction of GFR after Xe anesthesia to standard isoflurane (Iso) anesthesia.</s><s>Secondary outcome variables were further laboratory and clinical marker of kidney function, key anesthesia data, surgical data and malignancyassociated data during the observation period.</s><s>A long-term follow-up of renal function was obtained after 3-6 months following surgery.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design</head><p><s>This study was conducted between July 2013 and October 2015 as a prospective, mono-center, single-blinded, two-arm parallel group randomized controlled study.</s><s>It was approved by the Ethics Committee of the University of RWTH Aachen, Germany (EK 012/13, 15 th April 2013) and the German federal medicines agency (BfArM), and registered on ClinicalTrials.gov</s><s>(NCT01839084, April 2013).</s><s>The study was conducted in the University Hospital RWTH Aachen, in adherence to the Declaration of Helsinki.</s><s>The study protocol has not been published previously.</s><s>A detailed description of methods is provided as S1 Text.</s><s>This study is reported in adherence to the CONSORT guidelines.</s><s>CONSORT checklist is provided in S1 Table <ref type="table">.</ref></s><s>The original German study protocol is provided in S1 Appendix and the English translation in S2 Appendix.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Participants</head><p><s>After written informed consent, adult patients with a suspected renal carcinoma limited to one kidney and planned for PN were enrolled in this study.</s><s>Among exclusion criteria were CKD, ASA&gt;III, contraindication and known hypersensitivity to the study drugs, pre-existing severe cardiac disease, severe respiratory disease and neurological disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Randomization and blinding</head><p><s>The randomization sequence based on permuted blocks (allocation ratio 1:1) was computergenerated by an independent statistician (IMSIE, Cologne, Germany) and concealed by means of sealed, opaque envelopes.</s><s>Only the patient remained blinded during the whole study procedure.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Changes to methods after trial commencement</head><p><s>A double-blinded (investigator and patient) study procedure was originally planned.</s><s>During study conduction of the first patients it appeared unfeasible and dispensable to continue the double-blind procedure in clinical routine due to practical differences in anesthesia types and the examiner-independent nature of the primary outcome variable.</s><s>In agreement with the sponsor and the Ethics Committee the study was continued in a single-blinded manner.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Intervention</head><p><s>A detailed description is provided in the S1 Text.</s><s>In summary, all subjects received anesthesia induction with propofol, sufentanil and rocuronium, followed by tracheal intubation and ventilation with a closed-circuit respirator (Felix Dual™, Air Liquide Medical Systems, France).</s><s>The allocated anesthetic agent was administered according to the corresponding randomization envelope.</s><s>Patients in the Xe group were aimed to receive 60% inspired Xe with 40% oxygen and 1.2% end expiratory Iso with 40% oxygen in the Iso group.</s><s>Further drugs for maintenance of anesthesia were administered according to the patients' needs.</s><s>Two experienced surgeons (AH and DP) performed open PN surgery in accordance with the standard operating procedures of the urology department.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Primary endpoint</head><p><s>GFR was determined every day and its maximum decrease was determined between the preoperative value and the lowest value within the first seven postoperative days following PN.</s><s>GFR was calculated by a combined formula incorporating serum creatinine and serum cystatin C: 135 x min(Scr/κ, 1) α x max(Scr/κ, 1 )−0.601</s><s>x min(Scys/0.8, 1) −0.375 x max(Scys/0.8, 1) −0.711 x 0.995 Age [x 0.969 if female] [x 1.08 if black], where Scr is serum creatinine, Scys is serum cystatin C, κ is 0.7 for females and 0.9 for males, α is −0.248 for females and −0.207 for males, min indicates the minimum of Scr/κ or 1, and max indicates the maximum of Scr/κ or 1 <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b28">29]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Secondary endpoints</head><p><s>The following secondary endpoints were assessed:</s></p><p><s>• Patients'vital functions (baseline and daily during the hospital stay until discharge or postoperative day (POD) 7)</s></p><p><s>• Intraoperative data (surgery day)</s></p><p><s>• Routine laboratory data including perioperative GFR, cystatin C and creatinine values (baseline and daily during the hospital stay until discharge or postoperative day (POD) 7)</s></p><p><s>• Tumor-related data (surgery day)</s></p><p><s>• The kidney injury marker neutrophil gelatinase-associated lipocalin (NGAL) in serum (baseline, intraoperatively 5 minutes after termination of the tumor ground-treatment, in the post anesthesia care unit (PACU) and on POD 1)</s></p><p><s>• NGAL in urine (baseline, PACU, on POD 1 and 2, and on POD 7 (or at discharge, if earlier))</s></p><p><s>• Occurrence of adverse events (surgery day until discharge (if earlier) or POD 7)</s></p><p><s>• Optional follow-up of renal function after 3-6 months.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outcome measures</head><p><s>All patients underwent a maximum of 11 visits.</s><s>The study procedure is summarized in the S1</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study sample size calculation</head><p><s>According to the literature <ref type="bibr" target="#b4">[5]</ref> and our clinical experience, we assumed up to 30% decrease in GFR (corresponding to 54 ml min -1 1.73 −1 m -2 ) in a control group patient with normal preoperative renal function (180 ml min -1 1.73 −1 m -2 ).</s><s>A 10% reduction of the postoperative GFR decrease in the Xe group was considered as clinically significant.</s><s>This would correspond to a GFR decrease of 36 ml min -1 1.73 −1 m -2 .</s><s>Assuming a large standardized effect of 0.85, the ttest required 23 patients per group to reach 80% power at two-sided significance level 5%.</s><s>Expecting a dropout rate of 10%, we have decided to include 2 more patients per group, which yielded 25 patients per group in total.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical methods</head><p><s>The primary endpoint-maximum decrease of the GFR in the first seven days following PNwas evaluated by analysis of covariance adjusted for the baseline value.</s><s>Secondary endpoints were evaluated with Fisher's exact test (qualitative data) or Mann-Whitney U-test (quantitative data).</s><s>GraphPad PRISM 1 (GraphPad Software Inc., La Jolla, California, USA) was used to create figures.</s><s>All data were analyzed on intention-to-treat (ITT) basis, including all randomized patients, and on per-protocol (PP) basis, excluding subjects with unexpected radical nephrectomy.</s><s>Statistical calculations were performed with the software SPSS Statistics (version 23; IBM Corp., Armonk, NY, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>A detailed study flow chart is presented in Fig 1 <ref type="figure">.</ref></s><s>46 subjects were enrolled and equally randomized into the treatment-(n = 23 Xe) and control-group (n = 23 Iso).</s><s>No patient was excluded from final ITT analysis.</s><s>Five patients received an unexpected radical nephrectomy (Iso (n = 4) and Xe (n = 1)) due to medical reasons and were excluded from PP analysis.</s><s>Thus, we included 19 Iso patients and 22 Xe patients into PP analysis.</s><s>Outcome results, which are presented in our tables and figures, show the ITT analysis data as well as the PP analysis data.</s><s>All subjects completed primary endpoint analysis.</s><s>Given the optional character of our follow-up analysis; 18 patients were lost to follow-up for GFR determination after 3-6 months.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recruitment</head><p><s>Subjects were recruited between 07/2013 and 10/2015, and the last follow-up was conducted in February 2016.</s><s>Due to the unexpected leaving of both urological surgeons (Head of Department AH and DP) we had to stop subject recruitment earlier than expected, as this procedure was not performed any longer in the same way.</s><s>At this time only 46 patients were included, which was the minimal subject number to achieve the estimated power.</s><s>After discussion with all investigators and the sponsor, we decided to stop recruitment since comparable study conditions were no longer ensured.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline data</head><p><s>Patient baseline characteristics (Table <ref type="table" target="#tab_0">1</ref>) and pre-existing chronic diseases (S2 Table <ref type="table">)</ref> did not show any significant difference between the groups, except for the variable urea.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Primary outcome</head><p><s>The sample size for the PP analysis of the primary outcome included 19 patients in the Iso group and 22 patients in the Xe group.</s><s>Xe reduced the maximum postoperative GFR decrease by 45% compared to Iso in the PP analysis (P = 0.084) (Fig <ref type="figure" target="#fig_2">2A</ref>).</s><s>The maximum GFR decrease was 10.9 ml min -1 1.73 m -2 in the Xe group, and 19.7 ml min -1 1.73 m -2 in the Iso group (S3 Table <ref type="table">)</ref>.</s><s>Of note, the ITT analysis showed a significant P-value of 0.032 (Fig <ref type="figure" target="#fig_2">2B</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Secondary outcomes</head><p><s>Kidney function and markers of kidney injury.</s><s>The sample size for the PP analysis of the kidney-related secondary outcomes comprised 19 patients in the Iso group and 22 patients in the Xe group.</s><s>GFR showed the maximum decrease on POD 1, followed by a recovery to a new reduced baseline level until POD 7 in both groups (Fig <ref type="figure" target="#fig_3">3A</ref>).</s><s>Time-line of serum creatinine, cystatin C, and urea showed an initial increase on the POD 1, which was followed by a slower decrease back to baseline values until POD 7 in both groups (Fig 3B <ref type="figure" target="#fig_3">-3D</ref>).</s><s>Serum and urine NGAL showed a postoperative increase, which did not significantly differ between the groups (Fig 4A <ref type="figure" target="#fig_4">+ 4B</ref>).</s></p><p><s>Anesthesia and surgery-related data.</s><s>The sample size for the anesthesia and surgeryrelated data in the PP analysis consisted of 19 patients in the Iso group and 22 patients in the Xe group.</s><s>Intraoperative anesthesia-related data were collected during visit 1. Blood pressure was measured every 5 minutes; anesthetic gas and oxygen concentrations as well as the anesthesia depth and heart rate were measured continuously and documented every 5 minutes.</s><s>We revealed a significant difference in inspired oxygen concentration and the mean systolic and diastolic blood pressure in both statistical analyses (Table <ref type="table" target="#tab_2">2</ref>).</s><s>Patients in the Xe group received less inspired oxygen and the mean systolic and diastolic blood pressures were significantly higher in the Xe group.</s><s>Anesthesia depth, measured with bispectral index (BIS) monitoring was within the recommended margin of 40-60 in both groups (Table <ref type="table" target="#tab_2">2</ref>).</s></p><p><s>Surgery data were similar for both groups, with the exception of anesthetics exposure time before kidney manipulation, which was significantly prolonged in the Iso group (S4 Table <ref type="table">)</ref>.</s><s>No difference was found for surgery duration, kidney manipulation and hilar clamping time, anesthetic exposure time after kidney manipulation, intraoperative fluid input (crystalloids and colloids) and output (urine and blood loss).</s><s>Hilar clamping was performed in 17 patients Baseline creatinine [mg dl -1 ] 0.9 ± 0.2, 0.9 (0.2) 0.8 ± 0.1, 0.8 (0.1) 0.9 ± 0.2, 0.9 (0.2) 0.169</s></p><p><s>Baseline cystatin C [mg dl -1 ] 0.9 ± 0.2, 0.9 (0.3) 0.9 ± 0.2, 0.9 (0.3) 1.0 ± 0.2, 0.9 (0. (Iso (n = 8) and Xe (n = 9)).</s><s>The mean clamping duration was longer in the Xe group (S4 Table <ref type="table">)</ref>.</s><s>The maximum postoperative GFR decrease was higher in all patients with hilar clamping.</s><s>Of note, patients with Xe anesthesia had less GFR decrease compared to the Iso group even after hilar clamping (S3 Table <ref type="table">)</ref> Histological (tumor classification) and pathological (renal tissue excision volume, size and weight) analysis did not reveal any significant differences between the groups (S5 Table <ref type="table">)</ref>.</s></p><p><s>Adverse events.</s><s>Occurrence of adverse events was significantly lower in the Xe group (P = 0.003) (S6 Table <ref type="table">)</ref>.</s><s>The sample size in the PP analysis contained 19 patients in the Iso group and 22 patients in the Xe group.</s><s>Considering the individual events, there was a significant difference for intraoperative hypotension requiring catecholamine support in the Iso group compared to Xe.</s><s>A significantly increased incidence of anemia in the Iso group, due to postoperative bleeding via surgical drain or hematoma, was only present in the PP analysis.</s><s>Nausea, vomiting, AKI assessed according to the Acute Kidney Injury Network (AKIN) classification <ref type="bibr" target="#b29">[30]</ref> and the length of in-hospital stay were similar in both groups (S6 and S7 Tables).</s></p><p><s>Longer-term kidney function.</s><s>The optional longer-term analysis of kidney function was obtained after 3-6 months for 28 patients (Fig <ref type="figure" target="#fig_1">1</ref>  <ref type="table">)</ref>.</s><s>The PP analysis included 11 patients in the Iso group and 15 patients in the Xe group Renal function did not show any significant difference between the two patient groups and revealed a mean GFR of 78.9±16.6 ml min -1 1,73m -2 in the Iso and 82.1±16.0</s><s>ml min -1 1,73m -2 in the Xe group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>and S7 Table</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The present study is the first randomized clinical study, which could confirm that Xe anesthesia is feasible and safe in patients undergoing PN surgery with regard to the postoperative renal function.</s><s>We could not confirm preclinical results that report better kidney function in mice after exposure to Xe anesthesia and kidney IRI <ref type="bibr" target="#b20">[21]</ref>.</s><s>The result of a significantly attenuated GFR decrease was only found in the ITT analysis, whereas it did not differ in the PP analysis (P = 0.084).</s><s>The most likely reason for this difference between the ITT and PP analysis is the small sample size of our study and the unfortunately required exclusion of 5 nephrectomy patients from the PP analysis.</s><s>The decision to perform a radical nephrectomy was not dependent on the type of anesthetic, but on the anatomical size and condition of the tumor.</s><s>This decision was made during surgery and could not be foreseen at patient recruitment.</s><s>Patients with nephrectomies were excluded from the PP analysis, as the aim of this study was to preserve nephron function in surgery-related IRI by Xe, which is disrupted by nephrectomy.</s><s>This issue most likely hindered a powerful primary endpoint result.</s><s>Therefore, we cannot prove if Xe is nephroprotective and if we would have the same result with a higher PP sample size.</s><s>On the other hand, it remains controversial if the 4 patients with nephrectomies in the Iso group versus 1 nephrectomy patient in the Xe group were exclusively decisive for the significant difference in the ITT, due to the greater decline in GFR after nephrectomy independently of the used anesthetic.</s></p><p><s>Of note, we found a trend of reduced GFR decrease in the Xe group, despite the significantly longer Iso exposure before tumor manipulation, and despite a higher rate of hilar clamping with Xe.</s></p><p><s>A further important factor for preservation of postoperative organ function is the maintenance of intraoperative hemodynamic stability, which was more present in the Xe group.</s><s>Therefore, it remains unclear if Xe directly induces kidney function preservation or indirectly via more stabilized blood pressure during anesthesia.</s><s>But from the clinical point of view, both would be beneficial.</s><s>Of note, almost 50% of our patients (n = 12 in each group) had pre-existent arterial hypertension.</s><s>Especially, these patients may profit from higher and more stable intraoperative blood pressure, as their auto regulation of renal perfusion is usually shifted to a higher range <ref type="bibr" target="#b30">[31]</ref>.</s><s>We have chosen Iso as the comparative, as it was shown to have the strongest nephroprotective effect against IRI among commonly used volatile anesthetics <ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref>.</s><s>Furthermore, Iso does not exhibit potentially nephrotoxic effects like sevoflurane <ref type="bibr" target="#b34">[35]</ref>, and it was not inferior in clinical studies examining postoperative renal function after major surgery and renal transplantation compared to sevoflurane, desflurane or propofol anesthesia <ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref>.</s></p><p><s>In contrast to one large randomized clinical study comparing Iso and Xe anesthesia, we did not reveal a significant difference in mean heart rates <ref type="bibr" target="#b38">[39]</ref>.</s><s>Whereas Wappler et al. included only ASA I-II patients, we have also included eleven ASA III patients in our study.</s><s>Of note, the applied minimal alveolar concentration (MAC) could be a potential confounder for hemodynamic outcomes, but data regarding the MAC values for Xe are controversial <ref type="bibr" target="#b39">[40]</ref>.</s><s>Therefore, our MAC values have to be interpreted with care (Table <ref type="table" target="#tab_2">2</ref>).</s><s>Thus we used BIS monitoring to have some information on anesthesia depth in both groups.</s><s>The mean BIS values were comparable and within the recommended range.</s><s>The significantly higher applied mean inspired oxygen concentrations in the Iso group were not related to any anaesthesiological concern, but rather an accidental effect.</s><s>One explanation could be the technical circumstances of the ventilator, which provides a different anesthesia handling for gaseous Xe than for the volatile anesthetic Iso.</s><s>Serious adverse events did not occur in our study.</s><s>Interestingly, we could not confirm a significantly higher incidence of the diagnosis AKI according to the AKIN classification in the Iso group, even not in the ITT analysis.</s><s>This might be rooted in the combined use of creatinine/ cystatin for GFR evaluation in our study, contrary to the use of creatinine/ oliguria for AKI diagnosis <ref type="bibr" target="#b29">[30]</ref>.</s><s>Creatinine has been shown to be less sensitive in the detection of small declines of renal function than cystatin <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b40">41]</ref>.</s><s>Furthermore, our power calculation was performed for detection of maximum postoperative GFR decrease and not the incidence of AKI.</s><s>In addition, the early termination of our study has led to a drop in the number of subjects which otherwise would have completed the study.</s><s>Therefore, the higher incidence of postoperative anemia in the Iso group has to be seen within its limits, as it was only significant in the PP analysis and abolished in the ITT analysis.</s><s>To our opinion, the significantly higher baseline serum urea concentration in the Xe group was most likely an incidental finding, which did not influence our results.</s><s>Serum urea is known to lack sensitivity and specificity as a marker of renal function <ref type="bibr" target="#b41">[42,</ref><ref type="bibr" target="#b42">43]</ref>.</s></p><p><s>NGAL was identified as an early biomarker for AKI, appearing even before clinically apparent functional changes <ref type="bibr" target="#b43">[44]</ref>.</s><s>It is released from renal proximal tubular cells within 2 hours of kidney injury and can easily be detected in serum and urine <ref type="bibr" target="#b43">[44]</ref>.</s><s>We observed increased NGAL levels in all patients post-surgery in serum and particularly in urine samples, but only found a tendency to more increased urine NGAL levels in the Iso group compared to Xe.</s><s>Since NGAL was not the primary outcome parameter these results are merely descriptive.</s></p><p><s>Longer-term follow-up of kidney function after 3-6 months was successfully obtained for only 28 patients.</s><s>As pre-specified in our study protocol it was not feasible to perform followup in all patients, which came from all over Germany and even abroad.</s><s>According to the German law, these patients would need a separate insurance for follow-up investigations out of the clinical routine, which would go beyond the scope of this explorative study.</s><s>Therefore, this analysis was left to the discretion of the patients'family physicians and their routinely post-surgery care policy, which explains the high loss to follow-up and the different type of GFR estimation.</s><s>We did not find a significant difference in the mean GFR between the two groups.</s><s>One explanation could be the lower sensitivity of the creatinine-based GFR estimation method <ref type="bibr" target="#b27">[28]</ref>, beside the high loss to follow-up.</s><s>Further data are required to confirm or refute our results, as our study lacked power for this longer-term analysis.</s><s>If Xe does not preserve the potential short-term benefit, the clinical consequences of Xe anesthesia may be questioned, especially regarding the high costs of Xe anesthesia <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b44">45]</ref>.</s><s>Of note, only patients with normal preoperative GFR have been included in our study.</s><s>It was shown that patients with CKD and preoperatively impaired renal function are at risk for postoperative worsening of CKD and increased CKD-associated mortality <ref type="bibr" target="#b3">[4]</ref>.</s><s>It may be speculated but remains to be proven if Xe would have a stronger nephroprotective effect in these patients or in a larger study population, which would improve the cost-benefit ratio for Xe.</s></p><p><s>Clinical nephroprotection by an anesthetic like Xe might not only have an impact after renal surgery but also after further types of major surgery, like aortic repair.</s><s>Postoperative AKI occurs in 40% of these patients, and mortality is even increased with the need of renal replacement <ref type="bibr" target="#b20">[21]</ref>.</s><s>Furthermore, renal IRI frequently compromises renal graft function in transplantation <ref type="bibr" target="#b20">[21]</ref>.</s><s>Preclinical data show promising results with regard to the influence of Xe on renal grafts <ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref>.</s><s>Up to now there are no clinical RCTs including patients with impaired renal function <ref type="bibr" target="#b6">[7]</ref>.</s></p><p><s>The following limitations have to be acknowledged: This study was performed in a single hospital and the generalizability of our findings to other settings and populations remains unknown.</s></p><p><s>Though not significant, due to the high standard deviation the resection volume and weight was higher in the Iso than in the Xe group, despite similar tumor sizes.</s><s>The reason remains unclear and the influence on our results is questionable.</s><s>But these variations reflect the clinical routine of surgeries.</s><s>Concurrently, hilar clamping was performed in more Xe patients and the mean hilar clamping time was longer in the Xe group.</s><s>Nevertheless, this did not affect the effect of Xe on primary outcome.</s><s>Of note, the low rate of hilar clamping and the short clamping times in our center may be different to other hospitals.</s><s>Probably a nephroprotective effect of Xe could be enhanced after surgery with longer and more frequent hilar clamping, and the longer-term GFR would probably be different from baseline.</s><s>In addition, exclusion of patients with disturbed renal function in this explorative study has probably hindered a clinically significant outcome improvement, which could justify the high costs of Xe anesthesia <ref type="bibr" target="#b44">[45]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>Xe anesthesia in PN surgery showed no difference of early postoperative GFR decrease compared to Iso anesthesia.</s><s>But, even if we could not show a significant result of nephroprotection by Xe, the first hints of potential nephroprotection in patients with PN should not be disregarded.</s><s>Further RCTs are required to prove xenon´s possible nephroprotection in a larger heterogeneous population, especially in patients with preoperatively impaired renal function.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Fig. and described more extensively in the S1 Text.</s><s>In brief, the visits consisted of: Visit 0 (preoperative baseline visit), visit 1 (intraoperative visit), visit 2 (postoperative visit on the surgery day), visit 3 (POD 1), visit 4 (POD 2), visit 5 (POD 3), visit 6 (POD 4), visit 7 (POD 5), visit 8 (POD 6), visit 9 (POD 7), visit 10 (optional, 3-6 months after surgery).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. CONSORT-Flowchart.</s><s>The CONSORT-Flowchart depicts the study-flow from screening until the analysis.</s><s>Reasons for patient loss: % 4 patients were not randomized due to the unplanned earlier stopping of our study after our urological surgeons have left the institution.</s><s>§ (n = 10) primary physician did not control the renal function until 6 months after surgery.</s><s>$ (n = 7) primary physician did not control the renal function until 6 months after surgery, (n = 1) patient deceased within 2 months after surgery, due to another disease.</s><s>&amp; (n = 4) patients received total nephrectomy.</s><s># (n = 1) patient received total nephrectomy.</s><s>https://doi.org/10.1371/journal.pone.0181022.g001</s></p></div></figDesc><graphic coords="6,200.01,71.72,375.42,327.97" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Maximum glomerular filtration rate decrease within 7 days after renal surgery.</s><s>(A) Intention-to-Treat analysis of the maximum early glomerular filtration rate.</s><s>(B) Per-protocol analysis of the maximum early glomerular filtration rate in patients undergoing partial nephrectomy.</s><s>Five patients were excluded from this analysis due to radical nephrectomy.</s><s>Data are means ± standard deviation.</s><s>* Significant P-value.</s><s>BSA, body surface area; GFR, glomerular filtration rate.</s><s>https://doi.org/10.1371/journal.pone.0181022.g002</s></p></div></figDesc><graphic coords="8,200.01,78.01,301.95,383.07" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Early postoperative renal function.</s><s>(A) Perioperative glomerular filtration rate values (GFR) from preoperative until the 7 th postoperative day.</s><s>The respective P-values for the particular time-points were: P = 0.464 preoperatively, P = 0.715 POD 1, P = 0.507 POD 2, P = 0.703 POD 3, P = 0.988 POD 4, P = 0.959 POD 5, P = 0.908 POD 6, and P = 0.050 POD 7. (B) Perioperative serum cystatin C values from preoperative until the 7 th postoperative day.</s><s>The respective P-values for the particular time-points were: P = 0.339 preoperatively, P = 0.914 POD 1, P = 0.533 POD 2, P = 0.673 POD 3, P = 0.815 POD 4, P = 0.481 POD 5, P = 0.685 POD 6, and P = 0.050 POD 7. (C) Perioperative serum creatinine values from preoperative until the 7 th postoperative day.</s><s>The respective P-values for the particular time-points were: P = 0.150 preoperatively, P = 0.774 POD 1, P = 0.308 POD 2, P = 0.334 POD 3, P = 0.861 POD 4, P = 0.354 POD 5, P = 1.0 POD 6, and P = 0.513 POD 7. (D) Perioperative serum urea values from preoperative until the 7 th postoperative day.</s><s>The respective P-values for the particular time-points were: P = 0.007 preoperatively, P = 0.792 POD 1, P = 0.188 POD 2, P = 0.649 POD 3, P = 0.608 POD 4, P = 0.230 POD 5, P = 0.713 POD 6, and P = 0.076 POD 7. Of note, early postoperative kidney function was analyzed until the 7 th postoperative day or until discharge, if earlier.</s><s>Data on the 7 th postoperative day were only available for 3 patients of each group.</s><s>Data are means ± standard deviation.</s><s>* P-value &lt;0.05.</s><s>POD, postoperative day; PreOP, preoperative baseline values.https://doi.org/10.1371/journal.pone.0181022.g003</s></p></div></figDesc><graphic coords="9,200.01,78.01,357.28,244.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. Early postoperative course of NGAL in serum and urine.</s><s>(A) NGAL concentrations in serum were assessed from preoperative until the first postoperative day.</s><s>There was no statistically significant difference between the groups for each time-point (P = 0.958 preoperatively, P = 0.239 intraoperatively, P = 0.896 in PACU, and P = 0.979 on POD 1).</s><s>(B) NGAL concentrations in urine were assessed from preoperative until the postoperative day 7.</s><s>There was no statistically significant difference between the groups for each time-point (P = 0.053 preoperatively, P = 0.860 in PACU, P = 0.875 on POD 1, P = 0.273 on POD 2, and P = 0.627 on POD 7).</s><s>Data are means ± standard deviation.</s><s>IntraOP, intraoperative; NGAL, neutrophil gelatinaseassociated lipocalin; PACU, post anesthesia care unit; POD, postoperative day; preOP, preoperative baseline values.</s><s>https://doi.org/10.1371/journal.pone.0181022.g004</s></p></div></figDesc><graphic coords="10,200.01,78.01,281.65,416.07" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>S1Fig.</head><label></label><figDesc><div><p><s>Trial procedure.</s><s>(TIF)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 . Patient baseline characteristics. Group Total (n = 46) Isoflurane (n = 23) Xenon (n = 23) P-value a</head><label>1</label><figDesc></figDesc><table><row><cell>Sex: m/f [n] (%)</cell><cell>32/14 (69.9/30.4)</cell><cell>15/8 (65.2/34.8)</cell><cell>17/6 (73.9/26.1)</cell><cell>0.749</cell></row><row><cell>Age [yrs.]</cell><cell>60.2 ± 14.2, 59.5 (19)</cell><cell>60.0 ± 14.6, 61 (23)</cell><cell>60.4 ± 14.2, 59 (20)</cell><cell>0.912</cell></row><row><cell>Height [cm]</cell><cell>173 ± 9.2, 173 (21)</cell><cell>173 ± 8.7, 175 (12)</cell><cell>173 ± 9.8, 172 (14)</cell><cell>0.991</cell></row><row><cell>Weight [kg]</cell><cell>81.4 ± 14.9, 82 (24)</cell><cell>81.1 ± 16.1, 82 (26)</cell><cell>81.7 ± 14.0, 82 (23)</cell><cell>0.834</cell></row><row><cell>ASA I/II/III [n] (%)</cell><cell>4/31/11 (8.7/67.4/23.9)</cell><cell>2/17/4 (8.7/73.9/17.4)</cell><cell>2/14/7 8.7/60.9/30.4)</cell><cell>0.663</cell></row><row><cell>Preoperative baseline values of renal function variables</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Baseline GFR [ml min -1 1,73 cm -2 ]</cell><cell>88.5 ± 16.0, 87.9 (18.8)</cell><cell>90.2 ± 14.0, 85.6 (16)</cell><cell>86.7 ± 17.8, 88.0 (26.4)</cell><cell>0.668</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 . Anesthesia-related data. Analysis Intention to Treat Per Protocol Group Isoflurane (n = 23) Xenon (n = 23) P- value a Isoflurane (n = 19) Xenon (n = 22) P- value a</head><label>2</label><figDesc><div><p><s>Data were recorded every 5 minutes during anesthesia.Data are presented as mean ± standard deviation, median (interquartile range).</s></p></div></figDesc><table><row><cell>Duration of anesthesia [min]</cell><cell>191.8 ± 59.5, 176</cell><cell>162.0 ± 59.2, 153 (93)</cell><cell>0.093</cell><cell>191.4 ± 60.6, 176</cell><cell cols="2">160.1 ± 59.9, 147.5 (89) 0.102</cell></row><row><cell></cell><cell>(102)</cell><cell></cell><cell></cell><cell>(112)</cell><cell></cell><cell></cell></row><row><cell>Mean inspired oxygen [%] b</cell><cell>49.7 ± 6.6, 49.1 (10.1)</cell><cell>44.4 ± 4.6, 44.3 (5.5)</cell><cell>0.010</cell><cell>49.0 ± 6.5, 47.8 (10.9)</cell><cell>44.3 ±4.7, 44.2 (5.5)</cell><cell>0.028</cell></row><row><cell>Mean anesthetic concentration</cell><cell>0.8 ± 0.1 (0.7 MAC),</cell><cell>51.1 ± 2.5 (0.8 MAC),</cell><cell>-</cell><cell>0.8 ± 0.1 (0.7 MAC),</cell><cell>51.1 ± 2.5 (0.8 MAC),</cell><cell>-</cell></row><row><cell>[%] (MAC) b</cell><cell>0.8 (0.2)</cell><cell>51.4 (2.9)</cell><cell></cell><cell>0.9 (0.2)</cell><cell>51.5 (2.9)</cell><cell></cell></row><row><cell>Mean RR sys [mmHg] b</cell><cell>107.7 ± 7.7, 105.7</cell><cell>116.9 ± 14.4, 114.2</cell><cell cols="2">0.020 106.9 ± 7.4, 104.4 (12)</cell><cell>117.5 ± 14.4, 114.6</cell><cell>0.012</cell></row><row><cell></cell><cell>(12.1)</cell><cell>(26.9)</cell><cell></cell><cell></cell><cell>(26.4)</cell><cell></cell></row><row><cell>Mean RR dia [mmHg] b</cell><cell>64.5 ± 9.2, 64 (11.6)</cell><cell>73.9 ± 12.3, 75.1 (19.3)</cell><cell>0.011</cell><cell>63.6 ± 8.5, 64 (11.5)</cell><cell>74.8 ± 11.7, 76.2 (18.6)</cell><cell>0.003</cell></row><row><cell>Mean heart rate [bpm] b</cell><cell cols="2">65.2 ± 9.1, 65.7 (12.7) 61.6 ± 13.2, 57.9 (15.4)</cell><cell>0.116</cell><cell cols="2">64.0 ± 7.4, 63.7 (12.7) 61.8 ± 13.5, 57.5 (15.4)</cell><cell>0.182</cell></row><row><cell>Mean BIS b</cell><cell>49.2 ± 5.2, 48.6 (7.5)</cell><cell>48.9 ± 4.3, 48.9 (4.3)</cell><cell>0.752</cell><cell>49.7 ± 5.6, 49.4 (8.6)</cell><cell>48.8 ± 4.4, 48.8 (4.3)</cell><cell>0.615</cell></row><row><cell cols="7">BIS, bispectral index; bpm, beats per minute; MAC, minimum alveolar concentration; n, number; RR sys, systolic blood pressure; RR dia, diastolic blood</cell></row><row><cell>pressure.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">https://doi.org/10.1371/journal.pone.0181022.t002</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>a P-values are from Mann-Whitney U-test.b</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | https://doi.org/10.1371/journal.pone.0181022July 18, 2017  </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We would like to thank Angela Habier (Clinical Trial Center Aachen, University Hospital of RWTH Aachen, Germany) for her excellent support with the application and conduct of this study.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting information</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">International variations and trends in renal cell carcinoma incidence and mortality</title>
		<author>
			<persName><forename type="first">A</forename><surname>Znaor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lortet-Tieulent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laversanne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eururo.2014.10.002</idno>
		<idno type="PMID">25449206</idno>
		<ptr target="https://doi.org/10.1016/j.eururo.2014.10.002" />
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="519" to="530" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">EAU guidelines on renal cell carcinoma: 2014 update</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ljungberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bensalah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Canfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dabestani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hora</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eururo.2015.01.005</idno>
		<idno type="PMID">25616710</idno>
		<ptr target="https://doi.org/10.1016/j.eururo.2015.01.005" />
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="913" to="924" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Impact of kidney cancer surgery on oncologic and kidney functional outcomes</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.ajkd.2011.07.021</idno>
		<idno type="PMID">21956016</idno>
		<ptr target="https://doi.org/10.1053/j.ajkd.2011.07.021" />
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="846" to="854" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Demirjian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Derweesh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Velet</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eururo.2015.04.043</idno>
		<idno type="PMID">26012710</idno>
		<ptr target="https://doi.org/10.1016/j.eururo.2015.04.043" />
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="996" to="1003" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function</title>
		<author>
			<persName><forename type="first">O</forename><surname>Yossepowitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Eggener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Serio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Vickers</surname></persName>
		</author>
		<idno type="PMID">16952626</idno>
	</analytic>
	<monogr>
		<title level="j">J Urol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="1339" to="1343" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>discussion 1343</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients</title>
		<author>
			<persName><forename type="first">F</forename><surname>Kork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Balzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Spies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K-D</forename><surname>Wernecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Ginde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jankowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of the American Society of Anesthesiologists</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="1301" to="1311" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Xenon Anesthesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials</title>
		<author>
			<persName><forename type="first">Ls-C</forename><surname>Law</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ea-G</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Gan</surname></persName>
		</author>
		<idno type="DOI">10.1213/ANE.0000000000000914</idno>
		<idno type="PMID">26273750</idno>
		<ptr target="https://doi.org/10.1213/ANE.0000000000000914" />
	</analytic>
	<monogr>
		<title level="j">Anesth Analg</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="678" to="697" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dickinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Franks</surname></persName>
		</author>
		<idno type="DOI">10.1186/cc9051</idno>
		<idno type="PMID">20836899</idno>
		<ptr target="https://doi.org/10.1186/cc9051" />
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">229</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Xenon attenuates cardiopulmonary bypassinduced neurologic and neurocognitive dysfunction in the rat</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Franks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Grocott</surname></persName>
		</author>
		<idno type="PMID">12606913</idno>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="690" to="698" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Xenon preconditioning reduces brain damage from neonatal asphyxia in rats</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hossain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gkj</forename><surname>Pettet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Akimov</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.jcbfm.9600184</idno>
		<idno type="PMID">16034370</idno>
		<ptr target="https://doi.org/10.1038/sj.jcbfm.9600184" />
	</analytic>
	<monogr>
		<title level="j">J Cereb Blood Flow Metab</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="199" to="208" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury</title>
		<author>
			<persName><forename type="first">M</forename><surname>Coburn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Franks</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.CCM.0B013E3181611F8A6</idno>
		<idno type="PMID">18216607</idno>
		<ptr target="https://doi.org/10.1097/01.CCM.0B013E3181611F8A6" />
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="588" to="595" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hossain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Arshad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Battson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Sanders</surname></persName>
		</author>
		<idno type="DOI">10.1002/ana.20547</idno>
		<idno type="PMID">16049939</idno>
		<ptr target="https://doi.org/10.1002/ana.20547" />
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="182" to="193" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The effect of xenon anesthesia on the size of experimental myocardial infarction</title>
		<author>
			<persName><forename type="first">J-H</forename><surname>Baumert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gerets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Baltus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Hecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rossaint</surname></persName>
		</author>
		<idno type="DOI">10.1213/01.ane.0000284697.73471.9c</idno>
		<idno type="PMID">17959941</idno>
		<ptr target="https://doi.org/10.1213/01.ane.0000284697.73471.9c" />
	</analytic>
	<monogr>
		<title level="j">Anesth Analg</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="1200" to="1206" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Xenon and isoflurane improved biventricular function during right ventricular ischemia and reperfusion</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Roehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Baumert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bleilevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Steendijk</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1399-6576.2009.02116.x</idno>
		<idno type="PMID">19839950</idno>
		<ptr target="https://doi.org/10.1111/j.1399-6576.2009.02116.x" />
	</analytic>
	<monogr>
		<title level="j">Acta Anaesthesiol Scand</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="470" to="478" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Mio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Shim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">J</forename><surname>Bosnjak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Pagel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bienengraeber</surname></persName>
		</author>
		<idno type="DOI">10.1213/ane.0b013e318192a520</idno>
		<idno type="PMID">19224794</idno>
		<ptr target="https://doi.org/10.1213/ane.0b013e318192a520" />
	</analytic>
	<monogr>
		<title level="j">Anesth Analg</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="858" to="866" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stursberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Wirthle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Toma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Schlack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Preckel</surname></persName>
		</author>
		<idno type="DOI">10.1093/bja/ael153</idno>
		<idno type="PMID">16793779</idno>
		<ptr target="https://doi.org/10.1093/bja/ael153" />
	</analytic>
	<monogr>
		<title level="j">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="298" to="306" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Anticonvulsant effect of xenon on neonatal asphyxial seizures</title>
		<author>
			<persName><forename type="first">D</forename><surname>Azzopardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kapetanakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Griffiths</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Rennie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Mathieson</surname></persName>
		</author>
		<idno type="DOI">10.1136/archdischild-2013-303786</idno>
		<idno type="PMID">23572341</idno>
		<ptr target="https://doi.org/10.1136/archdischild-2013-303786" />
	</analytic>
	<monogr>
		<title level="j">Arch Dis Child Fetal Neonatal Ed</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="F437" to="F439" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial</title>
		<author>
			<persName><forename type="first">D</forename><surname>Azzopardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bainbridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Charles-Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Deierl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Laitio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hynninen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Arola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Virtanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Parkkola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Saunavaara</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2016.1933</idno>
		<idno type="PMID">26978207</idno>
		<ptr target="https://doi.org/10.1001/jama.2016.1933" />
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="page" from="1120" to="1128" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The Efficacy of Noble Gases in the Attenuation of Ischemia Reperfusion Injury: A Systematic Review and Meta-Analyses</title>
		<author>
			<persName><forename type="first">J</forename><surname>De Deken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rex</forename><forename type="middle">S</forename><surname>Monbaliu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pirenne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jochmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<idno type="DOI">10.1681/ASN.2008070712</idno>
		<idno type="PMID">19144758</idno>
		<ptr target="https://doi.org/10.1681/ASN.2008070712" />
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="713" to="720" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rizvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jawad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Vizcaychipi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Biol Med (Maywood)</title>
		<imprint>
			<biblScope unit="volume">235</biblScope>
			<biblScope unit="page" from="886" to="891" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice</title>
		<author>
			<persName><forename type="first">P</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Teng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">J</forename><surname>Bosnjak</surname></persName>
		</author>
		<idno type="DOI">10.1097/ALN.0b013e318298e5f1</idno>
		<idno type="PMID">23681145</idno>
		<ptr target="https://doi.org/10.1097/ALN.0b013e318298e5f1" />
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="621" to="630" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Watts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tralau-Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Maxwell</surname></persName>
		</author>
		<idno type="DOI">10.1111/ajt.12293</idno>
		<idno type="PMID">23710625</idno>
		<ptr target="https://doi.org/10.1111/ajt.12293" />
	</analytic>
	<monogr>
		<title level="j">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="2006" to="2018" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ologunde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>O'dea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Takata</surname></persName>
		</author>
		<idno type="DOI">10.1096/fj.13-232173</idno>
		<idno type="PMID">23759444</idno>
		<ptr target="https://doi.org/10.1096/fj.13-232173" />
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="4076" to="4088" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Early treatment with xenon protects against the cold ischemia associated with chronic allograft nephropathy in rats</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tralau-Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ajt</forename><surname>George</surname></persName>
		</author>
		<idno type="DOI">10.1038/ki.2013.334</idno>
		<idno type="PMID">24025645</idno>
		<ptr target="https://doi.org/10.1038/ki.2013.334" />
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="112" to="123" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Feasibility and safety of xenon compared with sevoflurane anaesthesia in coronary surgical patients: a randomized controlled pilot study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Stoppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Fahlenkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rex</forename><forename type="middle">S</forename><surname>Veeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Gozdowsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Scha ¨lte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<idno type="DOI">10.1093/bja/aet072</idno>
		<idno type="PMID">23578862</idno>
		<ptr target="https://doi.org/10.1093/bja/aet072" />
	</analytic>
	<monogr>
		<title level="j">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="406" to="416" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Estimating glomerular filtration rate from serum creatinine and cystatin C</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Inker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tighiouart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Eckfeldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">I</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Greene</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1114248</idno>
		<idno type="PMID">22762315</idno>
		<ptr target="https://doi.org/10.1056/NEJMoa1114248" />
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="20" to="29" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Cystatin C versus creatinine in determining risk based on kidney function</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Shlipak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matsushita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Inker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Polkinghorne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1214234</idno>
		<idno type="PMID">24004120</idno>
		<ptr target="https://doi.org/10.1056/NEJMoa1214234" />
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="932" to="943" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Molitoris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ronco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Warnock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<editor>R3131. Varon J, Marik PE</editor>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="615" to="627" />
			<date type="published" when="2007">2007. 2008</date>
		</imprint>
	</monogr>
	<note>Perioperative hypertension management. Vasc Health Risk Manag</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ota-Setlik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Nasr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Emala</surname></persName>
		</author>
		<idno type="PMID">15564938</idno>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="1313" to="1324" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Emala</surname></persName>
		</author>
		<idno type="DOI">10.1159/000105124</idno>
		<idno type="PMID">17622749</idno>
		<ptr target="https://doi.org/10.1159/000105124" />
	</analytic>
	<monogr>
		<title level="j">Am J Nephrol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="416" to="424" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Pre-treatment with isoflurane ameliorates renal ischemic-reperfusion injury in mice</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Vizcaychipi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.lfs.2011.04.004</idno>
		<idno type="PMID">21565202</idno>
		<ptr target="https://doi.org/10.1016/j.lfs.2011.04.004" />
	</analytic>
	<monogr>
		<title level="j">Life Sci</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="1102" to="1107" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ikeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ikeda</surname></persName>
		</author>
		<idno type="PMID">9197291</idno>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="1231" to="1237" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Changes in plasma creatinine concentration after cardiac anesthesia with isoflurane, propofol, or sevoflurane: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Story</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Poustie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Mcnicol</surname></persName>
		</author>
		<idno type="PMID">11605922</idno>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="842" to="848" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The effects of desflurane and isoflurane on hepatic and renal functions after right hepatectomy in living donors</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Gwak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chd</forename><surname>Kwon</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.transproceed.2012.01.016</idno>
		<idno type="PMID">22410038</idno>
		<ptr target="https://doi.org/10.1016/j.transproceed.2012.01.016" />
	</analytic>
	<monogr>
		<title level="j">Transplant Proc</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="442" to="444" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Sevoflurane versus isoflurane: does it matter in renal transplantation?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Teixeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Silva</forename><surname>Da</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Viana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mota</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.transproceed.2007.07.038</idno>
		<idno type="PMID">17954155</idno>
		<ptr target="https://doi.org/10.1016/j.transproceed.2007.07.038" />
	</analytic>
	<monogr>
		<title level="j">Transplant Proc</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="2486" to="2488" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery</title>
		<author>
			<persName><forename type="first">F</forename><surname>Wappler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rossaint</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Baumert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Scholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Tonner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Aken</surname></persName>
		</author>
		<idno type="PMID">17325504</idno>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="463" to="471" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Xenon: elemental anaesthesia in clinical practice</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maze</surname></persName>
		</author>
		<idno type="DOI">10.1093/bmb/ldh034</idno>
		<idno type="PMID">15728132</idno>
		<ptr target="https://doi.org/10.1093/bmb/ldh034" />
	</analytic>
	<monogr>
		<title level="j">Br Med Bull</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="115" to="135" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Dharnidharka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stevens</surname></persName>
		</author>
		<idno type="DOI">10.1053/ajkd.2002.34487</idno>
		<idno type="PMID">12148093</idno>
		<ptr target="https://doi.org/10.1053/ajkd.2002.34487" />
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="221" to="226" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Laboratory tests of renal function</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mcwilliam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Macnab</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anaesthesia &amp; Intensive Care Medicine</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="296" to="299" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">How to measure renal function in clinical practice</title>
		<author>
			<persName><forename type="first">J</forename><surname>Traynor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mactier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Geddes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Fox</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.38975.390370.7C</idno>
		<idno type="PMID">17023465</idno>
		<ptr target="https://doi.org/10.1136/bmj.38975.390370.7C" />
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page" from="733" to="737" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Acute kidney injury: novel biomarkers and potential utility for patient care in urology</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Demirjian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Simmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Goldfarb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Subramanian</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.urology.2010.05.004</idno>
		<idno type="PMID">20599252</idno>
		<ptr target="https://doi.org/10.1016/j.urology.2010.05.004" />
	</analytic>
	<monogr>
		<title level="j">Urology</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="5" to="11" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Xenon consumption during general surgery: a retrospective observational study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Stoppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rimek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rossaint</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rex</forename><forename type="middle">S</forename><surname>Stevanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scha ¨lte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<idno type="DOI">10.1186/2045-9912-3-12</idno>
		<idno type="PMID">23758970</idno>
		<ptr target="https://doi.org/10.1186/2045-9912-3-12" />
	</analytic>
	<monogr>
		<title level="j">Med Gas Res</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">12</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Will xenon be a stranger or a friend?: the cost, benefit, and future of xenon anesthesia</title>
		<author>
			<persName><forename type="first">T</forename><surname>Goto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Morita</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="1" to="2" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
